Healthcare provider profile · identity verified

Kenneth R Sharp, DO

Family Practice · LEHIGHTON, PA · NPI 1356340269

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	515	142
Levothyroxine Sodium	Levothyroxine Sodium	394	96
Lisinopril	Lisinopril	382	100
Losartan Potassium	Losartan Potassium	310	85
Amlodipine Besylate	Amlodipine Besylate	273	75
Pantoprazole Sodium	Pantoprazole Sodium	247	67
Metformin Hcl	Metformin Hcl	241	71
Simvastatin	Simvastatin	197	47
Omeprazole	Omeprazole	193	51
Alprazolam	Alprazolam	191	31
Metoprolol Succinate	Metoprolol Succinate	188	58
Gabapentin	Gabapentin	166	50
Eliquis	Apixaban	156	36
Furosemide	Furosemide	149	47
Metoprolol Tartrate	Metoprolol Tartrate	143	41
Albuterol Sulfate Hfa	Albuterol Sulfate	128	37
Hydrochlorothiazide	Hydrochlorothiazide	121	33
Tamsulosin Hcl	Tamsulosin Hcl	118	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	27
Citalopram Hbr	Citalopram Hydrobromide	101	30
Rosuvastatin Calcium	Rosuvastatin Calcium	98	27
Glimepiride	Glimepiride	92	31
Sertraline Hcl	Sertraline Hcl	88	29
Atenolol	Atenolol	80	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	23
Meloxicam	Meloxicam	80	28
Lorazepam	Lorazepam	79	20
Trazodone Hcl	Trazodone Hcl	75	18
Pioglitazone Hcl	Pioglitazone Hcl	74	26
Synthroid	Levothyroxine Sodium	70	18
Prednisone	Prednisone	69	34
Allopurinol	Allopurinol	66	19
Fluoxetine Hcl	Fluoxetine Hcl	64	18
Escitalopram Oxalate	Escitalopram Oxalate	62	24
Clonazepam	Clonazepam	60	13
Fluticasone Propionate	Fluticasone Propionate	60	19
Duloxetine Hcl	Duloxetine Hcl	59	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	13
Potassium Chloride	Potassium Chloride	57	15
Famotidine	Famotidine	56	18
Pravastatin Sodium	Pravastatin Sodium	54	17
Metformin Hcl Er	Metformin Hcl	53	16
Oxycodone Hcl	Oxycodone Hcl	53	11
Tramadol Hcl	Tramadol Hcl	51	13
Celecoxib	Celecoxib	50	14
Tizanidine Hcl	Tizanidine Hcl	49	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	47	14
Pregabalin	Pregabalin	44	11
Hydromorphone Hcl	Hydromorphone Hcl	41	suppressed
Ventolin Hfa	Albuterol Sulfate	40	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Buspirone Hcl	Buspirone Hcl	39	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Ibuprofen	Ibuprofen	36	11
Trulicity	Dulaglutide	36	suppressed
Methocarbamol	Methocarbamol	35	11
Montelukast Sodium	Montelukast Sodium	35	11
Benazepril Hcl	Benazepril Hcl	34	suppressed
Spironolactone	Spironolactone	34	14
Glipizide	Glipizide	33	14
Clopidogrel	Clopidogrel Bisulfate	31	11
Tradjenta	Linagliptin	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Nitroglycerin	Nitroglycerin	28	suppressed
Ozempic	Semaglutide	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Baclofen	Baclofen	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	11
Levetiracetam	Levetiracetam	22	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	22	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	21	suppressed
Finasteride	Finasteride	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Nystatin	Nystatin	19	12
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	13
Novolog Flexpen	Insulin Aspart	16	suppressed
Testosterone	Testosterone	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Bumetanide	Bumetanide	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Topiramate	Topiramate	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Armour Thyroid	Thyroid,pork	13	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Fluconazole	Fluconazole	13	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Kerendia	Finerenone	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Temazepam	Temazepam	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Repaglinide	Repaglinide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error